Topical treatment with BAY b 5097, a new broad spectrum antimycotic agent.
D000287:Administration, Topical; D000293:Adolescent; D000328:Adult; D000368:Aged; D000893:Anti-Inflammatory Agents; D000935:Antifungal Agents / Q000008:administration & dosage*; D002176:Candida albicans; D002179:Candidiasis, Cutaneous / Q000188:drug therapy*; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D014005:Tinea / Q000188:drug therapy*; D014006:Tinea Capitis / Q000188:drug therapy; D014008:Tinea Pedis / Q000188:drug therapy; D014249:Trichophyton
D000893:Anti-Inflammatory Agents; D000935:Antifungal Agents